Angion Biomedica Borrow Rate Increases to 183.97%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Latest data shows the largest indicative borrow rate increases among liquid option names include: Beyond Meat (BYND) 67.94% +7.02, Lucid Group (LCID) 45.82% +3.70, BioSig Technologies Inc (STEX) 7.52% +2.35, QXO Inc (QXO) 3.73% +1.69, BioCryst (BCRX) 2.20% +1.44, Rezolve AI Ltd (RZLV) 95.02% +1.35, Tidal Trust II (IRE) 23.77% +1.32, Bilibili (BILI) 2.07% +0.67, Canopy Growth (CGC) 19.33% +0.66, and Angion Biomedica Corp (ELTX) 183.97% +0.65.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BYND?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BYND
Wall Street analysts forecast BYND stock price to rise
4 Analyst Rating
0 Buy
1 Hold
3 Sell
Moderate Sell
Current: 0.709
Low
0.80
Averages
0.93
High
1.00
Current: 0.709
Low
0.80
Averages
0.93
High
1.00
About BYND
Beyond Meat, Inc. is a plant-based meat company offering a portfolio of plant-based meats. The Company sells a range of plant-based meat products across its three core platforms of beef, pork and poultry. The primary components of animal-based meat are amino acids, lipids, carbohydrates, trace minerals and water, which are not exclusive to animals and are plentiful in plants. Its beef platform products contain protein primarily derived from one or a combination of pea protein, rice protein, faba bean protein and wheat gluten. Its pork platform products include Beyond Sausage, Beyond Breakfast Sausage Patties, Beyond Breakfast Sausage Links and Beyond Sausage Crumbles. Its poultry platform consists of products that mimic animal-based chicken in its various merchandised forms, including chicken tenders, chicken nuggets and popcorn chicken. Its primary products under its poultry platform include Beyond Chicken Tenders, Beyond Chicken Nuggets and Beyond Popcorn Chicken.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Retail Launch: Beyond Meat has debuted Beyond Steak Filet at Wegmans and H-E-B, marking its first entry into retail, which is expected to enhance brand visibility and market share significantly.
- Positive Consumer Feedback: Since its launch on the brand's direct-to-consumer site in October 2025, Beyond Steak Filet has become the top-selling product, with consumers praising its delicious taste and nutritional profile, indicating strong market demand.
- Nutritional Highlights: Each serving of Beyond Steak Filet contains 28g of plant protein, 3g of fiber, and only 1g of saturated fat, made with healthy mycelium and avocado oil, catering to consumer preferences for healthier eating options while establishing a strong health-oriented brand image.
- Strategic Market Implications: The introduction of Beyond Steak Filet not only expands Beyond Meat's product line but also reinforces its leadership in the plant protein market by incorporating the innovative ingredient mycelium, signaling potential for future growth opportunities.
See More
- Revenue Decline: Beyond Meat's revenue has plummeted from $465 million in 2021 to $276 million in 2025, indicating four consecutive years of no growth, which reflects a challenging market environment with declining demand and increased competition.
- Gross Margin Erosion: The company's aggressive markdowns to liquidate inventory have led to a drastic reduction in gross margin from 25.2% in 2021 to 2.8% in 2025, severely impacting profitability and exacerbating its financial struggles.
- Strategic Transformation Challenges: Beyond Meat aims to rebrand itself with new products like
See More
- Revenue Decline: Beyond Meat's Q1 net revenue fell by 15% year-over-year to just over $58 million, missing analyst expectations of $59.6 million, indicating weak market demand that could undermine future investment confidence.
- Net Loss Situation: The company narrowed its net loss to $46.8 million ($0.10 per share), yet this still exceeded last year's $59 million loss, reflecting challenges in cost control that may heighten investor concerns about its financial health.
- Sales Volume Drop: Product sales volume plummeted nearly 20%, and while net revenue per pound increased by over 5%, it failed to offset the decline, suggesting severe competition in retail and food service channels that could impact market share.
- New Product Launch: Beyond Meat introduced the Beyond Immerse line of plant-based protein drinks, which investors welcomed; however, the intense competition in the already saturated beverage market may hinder its ability to secure a foothold.
See More
- Revenue Decline: Beyond Meat's first-quarter net revenue fell by 15% year-over-year to just over $58 million, missing analyst expectations of $59.6 million, indicating significant pressure in a competitive market.
- Net Loss Situation: The company managed to narrow its non-GAAP net loss to $46.8 million ($0.10 per share), yet it remains deeply in the red, reflecting ongoing challenges in profitability.
- Sales Volume Drop: Beyond Meat experienced a nearly 20% decline in product volume sold across both retail and food service channels, signaling weak consumer demand that adversely affects market share.
- New Beverage Launch: The introduction of Beyond Immerse, a line of plant-based beverages, has garnered investor interest; however, it faces stiff competition in a crowded beverage market filled with health-oriented options, limiting potential market opportunities.
See More
- Sales Decline: Beyond Meat reported a net revenue of $275 million in 2025, reflecting a 16% year-over-year drop, indicating waning consumer interest in its plant-based meat products, which has severely impacted market confidence and investor sentiment.
- Increased Operating Losses: The company's operating losses surged to $333 million in 2025, more than doubling from 2024, as the cost of goods sold nearly matched revenue, highlighting ongoing profitability challenges that necessitated a strategic pivot.
- New Product Launch: In response to these challenges, Beyond Meat launched its Beyond Immerse protein drink line in January 2026, entering a $35 billion market projected to grow at a 9.4% CAGR; however, the company's lack of commitment to this product line raises doubts about its potential to regain investor confidence.
- Poor Financial Performance: In Q1 2026, Beyond Meat's net revenue fell to $58 million, down 15% year-over-year, and while losses improved, the absence of any signs of financial recovery suggests that investors should remain cautious about the company's future performance.
See More
- Market Challenges: According to research data, the protein drink industry is growing at high single-digit levels, while Beyond Meat's net revenue fell to $275 million in 2025, down 16% year-over-year, indicating a decline in consumer interest in its plant-based meat products and resulting in severe financial challenges for the company.
- Product Launch: Beyond Meat launched its Beyond Immerse line of protein drinks in January 2026, and although the market is projected to reach $35 billion with a 9.4% CAGR through 2032, the product's limited-time offering has failed to boost investor confidence significantly.
- Deteriorating Financials: In Q1 2026, Beyond Meat reported net revenue of $58 million, a 15% year-over-year decline, and while losses improved from $61 million to $28 million, the company has yet to show signs of financial recovery, reflecting its vulnerable position in a competitive beverage market.
- Bleak Investment Outlook: Competing against industry giants like PepsiCo and Coca-Cola, Beyond Meat's protein drinks have not proven to be the turnaround catalyst needed for its stock, leading investors to approach the stock with caution unless the products gain traction and demonstrate sales growth.
See More









